[go: up one dir, main page]

MX2019009777A - Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas. - Google Patents

Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas.

Info

Publication number
MX2019009777A
MX2019009777A MX2019009777A MX2019009777A MX2019009777A MX 2019009777 A MX2019009777 A MX 2019009777A MX 2019009777 A MX2019009777 A MX 2019009777A MX 2019009777 A MX2019009777 A MX 2019009777A MX 2019009777 A MX2019009777 A MX 2019009777A
Authority
MX
Mexico
Prior art keywords
tablets
systems
methods
manufacture
including pharmaceutical
Prior art date
Application number
MX2019009777A
Other languages
English (en)
Inventor
S Myerson Allan
A Azad Mohammad
J Hammersmith Gregory
Brancazio David
Guillermo OSORIO CAICEDO Juan
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of MX2019009777A publication Critical patent/MX2019009777A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/84—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins
    • B01F33/844—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins with means for customizing the mixture on the point of sale, e.g. by sensing, receiving or analysing information about the characteristics of the mixture to be made
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/84—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins
    • B01F33/844—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins with means for customizing the mixture on the point of sale, e.g. by sensing, receiving or analysing information about the characteristics of the mixture to be made
    • B01F33/8442—Mixing plants with mixing receptacles receiving material dispensed from several component receptacles, e.g. paint tins with means for customizing the mixture on the point of sale, e.g. by sensing, receiving or analysing information about the characteristics of the mixture to be made using a computer for controlling information and converting it in a formula and a set of operation instructions, e.g. on the point of sale
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/32—Component parts, details or accessories; Auxiliary operations
    • B29C43/34—Feeding the material to the mould or the compression means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
    • B30B11/027—Particular press methods or systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
    • B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B15/00—Details of, or accessories for, presses; Auxiliary measures in connection with pressing
    • B30B15/30—Feeding material to presses
    • B30B15/302—Feeding material in particulate or plastic state to moulding presses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se proporcionan sistemas y métodos para la fabricación de tabletas farmacéuticas ingeribles; algunos de los sistemas y métodos que se describen en la presente pueden fabricar tabletas de diferentes dosis sin la necesidad de conectar o desconectar de manera fluida las operaciones unitarias cuando se cambia de una tableta que tiene una primera dosis a una tableta que tiene una segunda dosis diferente; algunos de los sistemas y métodos que se describen en la presente pueden fabricar tabletas de composición, por ejemplo, tabletas con diferentes ingredientes farmacéuticos activos (API).
MX2019009777A 2017-02-17 2018-02-15 Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas. MX2019009777A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762460626P 2017-02-17 2017-02-17
US201862619638P 2018-01-19 2018-01-19
US201862621429P 2018-01-24 2018-01-24
PCT/US2018/018359 WO2018152320A1 (en) 2017-02-17 2018-02-15 Systems and methods for the fabrication of tablets, including pharmaceutical tablets

Publications (1)

Publication Number Publication Date
MX2019009777A true MX2019009777A (es) 2019-10-14

Family

ID=61283424

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009777A MX2019009777A (es) 2017-02-17 2018-02-15 Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas.

Country Status (9)

Country Link
US (2) US10702481B2 (es)
EP (1) EP3582741B1 (es)
JP (2) JP7577292B2 (es)
KR (1) KR102558187B1 (es)
AU (1) AU2018221725B2 (es)
BR (1) BR112019015904A2 (es)
CA (1) CA3053784A1 (es)
MX (1) MX2019009777A (es)
WO (1) WO2018152320A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019015904A2 (pt) 2017-02-17 2020-03-24 Massachusetts Institute Of Technology Sistemas e métodos para a fabricação de comprimidos, incluindo comprimidos farmacêuticos
JP7118416B2 (ja) 2018-08-30 2022-08-16 株式会社菊水製作所 粉体圧縮成形システム及びその制御方法
WO2020081888A1 (en) 2018-10-19 2020-04-23 Matharu Amol S Portable apparatus and method for sterile pharmaceutical manufacturing
US11746040B2 (en) * 2018-11-05 2023-09-05 Andrea Wolf Ceramic glaze mixer control
DE112019006582A5 (de) * 2019-01-07 2022-01-13 Fritz Schmitt Vorrichtung für die Tablettierung einer pulverförmigen, flüssigen, pastösen, verkapselten oder granularen Wirkstoffzusammensetzung
JP7300708B2 (ja) * 2019-04-01 2023-06-30 株式会社菊水製作所 粉体を用いる処理システム及びその制御方法
US11911719B2 (en) 2019-09-20 2024-02-27 Massachusetts Institute Of Technology Devices and methods for the integrated filtration, drying, and mechanical processing of active pharmaceutical ingredients
DE102020115777A1 (de) * 2020-06-16 2021-12-16 Fette Compacting Gmbh Verfahren zur Produktverfolgung in einer Anlage
DE102020115919A1 (de) * 2020-06-17 2021-12-23 Fette Compacting Gmbh Verfahren zum Betreiben einer Mischeinrichtung einer Anlage
US20230143386A1 (en) * 2021-11-05 2023-05-11 Taiwan Mercury Medical Corporation Oral drug tablet manufacturing device and manufacturing method thereof
BE1032711B1 (fr) * 2024-06-21 2026-01-28 Pharma Tech Dispositif et procede de production de medicaments

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441498A (en) 1943-07-15 1948-05-11 Astra Apotekarnes Kem Fab Alkyl glycinanilides
US2421714A (en) 1944-04-18 1947-06-03 Parke Davis & Co Dialkylaminoalkyl benzhydryl ethers and salts thereof
JPS62235115A (ja) * 1986-04-07 1987-10-15 Ee & D:Kk 圧電型振動子を用いた振動フイ−ダ
JPS635900A (ja) * 1986-06-24 1988-01-11 Shinko Electric Co Ltd 粉粒体定量混合供給装置付き圧縮成型機
US20050042149A1 (en) 1994-04-01 2005-02-24 Integrated Chemical Synthesizers, Inc. Nanoscale chemical synthesis
US6558633B1 (en) 1994-09-21 2003-05-06 Isis Pharmaceuticals, Inc. Chemical reaction apparatus and methods
JPH09271996A (ja) * 1996-04-05 1997-10-21 Sankyo Co Ltd タブレット自動成形装置
JP3490577B2 (ja) * 1996-08-22 2004-01-26 日立粉末冶金株式会社 粉末成形装置の粉末供給装置
DE19959249A1 (de) 1999-12-08 2001-07-19 Inst Mikrotechnik Mainz Gmbh Modulares Mikroreaktionssystem
AU774311B2 (en) * 2000-01-31 2004-06-24 Lab21, Inc. Method and system for producing customized cosmetic and pharmaceutical formulations on demand
US7241423B2 (en) 2000-02-03 2007-07-10 Cellular Process Chemistry, Inc. Enhancing fluid flow in a stacked plate microreactor
AU2001283076A1 (en) 2000-08-14 2002-02-25 Chevron U.S.A. Inc. Use of microchannel reactors in combinatorial chemistry
JP2004537338A (ja) * 2001-03-02 2004-12-16 ユーロ−セルティーク，エス．エイ． 個別の投与剤形を調合するための方法と装置
DE60221238T2 (de) * 2001-05-01 2007-10-31 Pfizer Products Inc., Groton Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
US8636173B2 (en) * 2001-06-01 2014-01-28 Cosmetic Technologies, L.L.C. Point-of-sale body powder dispensing system
CA2478556A1 (en) 2002-03-22 2003-10-02 Michael Almstetter Methods and systems for discovery of chemical compounds and their syntheses
JP3373504B2 (ja) 2002-04-12 2003-02-04 株式会社湯山製作所 薬剤包装装置
US7108789B2 (en) 2002-07-29 2006-09-19 Calgon Carbon Corporation High performance continuous reaction/separation process using a continuous liquid-solid contactor
US20040028765A1 (en) * 2002-08-12 2004-02-12 Tiy Inc. Apparatus for home-made tablet-making
US8075778B2 (en) 2003-03-25 2011-12-13 Massachusetts Institute Of Technology Fluid separation
US20050175519A1 (en) 2004-02-06 2005-08-11 Rogers William A.Jr. Microchannel compression reactor
DE102005028897A1 (de) 2005-06-17 2006-12-28 Eckert & Ziegler Eurotope Gmbh Anordnung und Verfahren zur Verarbeitung von chemischen Stoffen, Computerprogramm zur Steuerung einer solchen Anordnung sowie ein entsprechendes computerlesbares Speichermedium
US20090282978A1 (en) 2005-07-05 2009-11-19 Massachusetts Institute Of Technology Microfluidic Separators for Multiphase Fluid-Flow Based On Membranes
WO2007070843A2 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
JP4757051B2 (ja) * 2006-02-13 2011-08-24 花王株式会社 柔軟物内蔵タブレット
US7641860B2 (en) 2006-06-01 2010-01-05 Nanotek, Llc Modular and reconfigurable multi-stage microreactor cartridge apparatus
US7854902B2 (en) 2006-08-23 2010-12-21 Nanotek, Llc Modular and reconfigurable multi-stage high temperature microreactor cartridge apparatus and system for using same
US20100324157A1 (en) 2006-12-29 2010-12-23 Bauman Richard F High throughput fischer-tropsch catalytic process development method
WO2008091694A2 (en) 2007-01-23 2008-07-31 Siemens Medical Solutions Usa, Inc. Fully-automated microfluidic system for the synthesis of radiolabeled biomarkers for positron emission tomography
WO2008150451A2 (en) 2007-05-30 2008-12-11 Velocys, Inc. Oxidative coupling of methane
BE1017763A5 (nl) 2007-09-24 2009-06-02 Proviron Holding Bioreactor.
US9052228B2 (en) 2009-03-06 2015-06-09 Nicole Sollazzo Lee Precision measurement dispenser
HU230862B1 (hu) 2008-04-28 2018-10-29 DARHOLDING Vagyonkezelő Kft Berendezés és eljárás nanorészecskék folyamatos üzemű előállítására
MX2010011962A (es) * 2008-04-30 2010-11-30 Novartis Ag Proceso continuo para hacer composiciones farmaceuticas.
WO2010021719A1 (en) 2008-08-19 2010-02-25 The Regents Of The University Of California Modular radiochemistry synthesis system
WO2010075389A2 (en) 2008-12-23 2010-07-01 Xoma Technology, Ltd. Flexible manufacturing system
CN102438578A (zh) 2009-05-07 2012-05-02 基伊埃制药系统有限公司 药片生产模块和用于连续生产药片的方法
US8426630B2 (en) 2009-08-31 2013-04-23 Florida State University Research Foundation Method and apparatus for continuous flow synthesis of ibuprofen
US8066873B2 (en) 2010-03-26 2011-11-29 Kaw Eros G Floating bioreactor system
US8287762B2 (en) 2010-04-02 2012-10-16 Air Products And Chemicals, Inc. Operation of staged membrane oxidation reactor systems
EP3578522A1 (en) 2010-12-06 2019-12-11 Pall Corporation Continuous processing methods for biological products
US20120325469A1 (en) 2011-06-27 2012-12-27 Olson Stephen W Process and system for treating produced water and flowback water from oil and gas operations
JP5968683B2 (ja) 2012-05-29 2016-08-10 株式会社日立製作所 粉体分注装置
GB201211305D0 (en) * 2012-06-26 2012-08-08 Gamlen Michael Tablet press
WO2014207510A1 (en) * 2013-06-27 2014-12-31 Gea Process Engineering Nv Method for continuous production of tablets, tabletting system for carrying out the method, and use of the tabletting system for the production of tablets of at least two ingredients containing particles with a significant difference in particle size
DE102014105058A1 (de) * 2014-04-09 2015-10-15 Stephanie Ittstein Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung
EP3180118A4 (en) 2014-08-15 2018-04-04 Massachusetts Institute Of Technology Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients
DE202015103051U1 (de) * 2015-04-20 2016-07-21 Korsch Ag Tablettiermaschine mit einer Vorrichtung zur Ausführung einer Dashboard- Anwendung
US9440381B1 (en) * 2015-06-12 2016-09-13 Kamal Shaham Manually operated tablet press
GB2543579B (en) * 2015-10-23 2018-06-06 Gamlen Michael Pivoting tablet die
JP6775311B2 (ja) * 2016-03-29 2020-10-28 株式会社菊水製作所 成形品製造システム
BR112019015904A2 (pt) 2017-02-17 2020-03-24 Massachusetts Institute Of Technology Sistemas e métodos para a fabricação de comprimidos, incluindo comprimidos farmacêuticos

Also Published As

Publication number Publication date
JP7486236B2 (ja) 2024-05-17
WO2018152320A1 (en) 2018-08-23
EP3582741B1 (en) 2023-07-26
US10702481B2 (en) 2020-07-07
BR112019015904A2 (pt) 2020-03-24
EP3582741A1 (en) 2019-12-25
AU2018221725B2 (en) 2024-02-01
EP3582741C0 (en) 2023-07-26
AU2018221725A1 (en) 2019-08-08
KR102558187B1 (ko) 2023-07-24
CA3053784A1 (en) 2018-08-23
US11020352B2 (en) 2021-06-01
KR20190116415A (ko) 2019-10-14
JP2023053954A (ja) 2023-04-13
JP2020510636A (ja) 2020-04-09
US20200352865A1 (en) 2020-11-12
WO2018152320A8 (en) 2018-10-04
US20180271791A1 (en) 2018-09-27
JP7577292B2 (ja) 2024-11-05

Similar Documents

Publication Publication Date Title
MX2019009777A (es) Sistemas y metodos para la fabricacion de tabletas, que incluyen tabletas farmaceuticas.
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
MX2021009475A (es) Composiciones farmaceuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano.
GT201700234A (es) Derivados de indol mono o disustituidos como inhibidores de la replicación viral del dengue
SA521421645B1 (ar) بيرولينات إندماجية تعمل كمثبطات بروتياز نوعي لأوبيكويتين 30
MX2021014747A (es) Sistemas y metodos para sintetizar productos quimicos, incluyendo ingredientes farmaceuticos activos.
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
DOP2016000254A (es) Formulaciones farmeceuticas de inhibidor de la quinasa pan-raf, procedimientos para su preparacion, y metodos de uso.
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
MX2017003561A (es) Composiciones y metodos para revestimientos cannabinoides para su uso en la administracion de farmacos.
UY37342A (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
MX2017000676A (es) Oritavancina de alta pureza y metodo para producir la misma.
MX2017016774A (es) Agente terapeutico para la fibrosis.
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
MX2025000572A (es) Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas
CL2021002107A1 (es) Triamtereno o nolatrexed para uso en el tratamiento de fenilcetonuria.
MX2018010065A (es) Forma de dosificacion oral que comprende rifaximina en forma beta.
PE20130529A1 (es) Terapia de combinacion que comprende un antagonista de ccr5, un inhibidor de proteasa de vih-1, y un potenciador farmacocinetico
MX2018012224A (es) Formulaciones farmacéuticas de liberación retardada que comprenden ácido valproico y usos de estas.
ECSP19006687A (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl-1, usos y composiciones farmacéuticas de éstos
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
MX2017013634A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
MX2017013643A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y una matriz.
CL2020002611A1 (es) Una composición farmacéutica en polvo seco para inhalación que comprende una hormona tiroidea
PH12016502591B1 (en) Pharmaceutical for treating dizziness having different causes